Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy

Michael J. Peluso, Peter Bacchetti, Kristen D. Ritter, Subul Beg, Jun Lai, Jeffrey N. Martin, Peter W. Hunt, Timothy J. Henrich, Janet D. Siliciano, Robert F. Siliciano, Gregory M. Laird, Steven G. Deeks

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Abstract

BACKGROUND. The relative stabilities of the intact and defective HIV genomes over time during effective antiretroviral therapy (ART) have not been fully characterized. METHODS. We used the intact proviral DNA assay (IPDA) to estimate the rate of change of intact and defective proviruses in HIV-infected adults on ART. We used linear spline models with a knot at seven years and a random intercept and slope up to the knot. We estimated the influence of covariates on rates of change. RESULTS. We studied 81 individuals for a median of 7.3 (IQR 5.9-9.6) years. Intact genomes declined more rapidly from initial suppression through seven years (15.7% per year decline; 95% CI-22.8%, -8.0%) and more slowly after seven years (3.6% per year; 95% CI-8.1%, +1.1%). The estimated half-life of the reservoir was 4.0 years (95% CI 2.7-8.3) until year seven and 18.7 years (95% CI 8.2-infinite) thereafter. There was substantial variability between individuals in the rate of decline until year seven. Intact provirus declined more rapidly than defective provirus (P < 0.001) and showed a faster decline in individuals with higher CD4+ T cell nadirs. CONCLUSION. The biology of the replication-competent (intact) reservoir differs from that of the replication-incompetent (non-intact) pool of proviruses. The IPDA will likely be informative when investigating the impact of interventions targeting the reservoir.

Original languageEnglish (US)
Article numbere132997
JournalJCI Insight
Volume5
Issue number4
DOIs
StatePublished - Feb 27 2020

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Differential decay of intact and defective proviral DNA in HIV-1–infected individuals on suppressive antiretroviral therapy'. Together they form a unique fingerprint.

Cite this